| Literature DB >> 27280621 |
Siu-Kei Chow1, Ederlyn E Atienza1, Linda Cook1, Harry Prince2, Patricia Slev3, Mary Lapé-Nixon2, Keith R Jerome4.
Abstract
Serology remains critical for diagnosing hepatitis D virus (HDV) infection, which affects 15 to 20 million people worldwide, but the literature on characterizing commercial enzyme immunoassays (EIAs) dates back to 15 years ago. We evaluated 2 commercial EIAs currently available for detecting anti-HDV antibodies. The DiaSorin assay demonstrated 100% sensitivity and specificity. Using a modified cutoff value, the Cusabio assay demonstrated a sensitivity of 81.3% and specificity of 90.9%. Our data show that recently developed EIAs are reliable for anti-HDV antibody detection.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27280621 PMCID: PMC4979180 DOI: 10.1128/CVI.00028-16
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X